Effect of Atorvastatin Treatment on Vascular Aterogenic Factors (Lipid Profiles and VCAM-1) in Patient Diabetes with Dyslipidemia

Mukti, Asri Wido

doi:10.14499/indonesianjpharm30iss2pp128-132

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Vaccine Implementation stating diabetes and cardiovascular diseases affected many people where this metabolic disorder is caused by hyperglycemia. Diabetic patients may be vaccinated if there is no acute complication (Sari, 2016;Mukti, 2019;Kemenkes, 2021).…”

Section: Proceeding the First Muhammadiyahmentioning

confidence: 99%

Willingness of Indonesian Public on The Vaccination Programme as an Effort to Prevent Covid-19

Olivina

2021

MIPHMP

View full text Add to dashboard Cite

The number of Covid-19 cases continues to increase, including in Indonesia. One of the efforts made by the Indonesian government to prevent a pandemic is to create and implement a Covid-19 vaccination program for the community. Therefore, the government is trying to urge the public to be willing to carry out a Covid-19 vaccine. This study was conducted to the willingness of the Indonesian public to the vaccination program as an effort to prevent Covid-19. The research method used is a qualitative approach by analyzing subjectively through the literature review method from PubMed, Clinical Key, Google Scholar, and Google Engine in Indonesian or English. The results showed that most Indonesians were willing to be vaccinated. However, there are also Indonesians who refuse to be vaccinated. The reason people refuse to be vaccinated against Covid-19 may be that they have different beliefs about the Covid-19 vaccine because of limited information about the type of vaccine, the availability of the vaccine, and the safety of the vaccine itself. the conclusion is that quite a lot of Indonesian people are willing to receive vaccinations but the government still needs to provide information, knowledge, and education about vaccination programs by involving all parties, both directly and the media so that Indonesian people who refuse or receive vaccines have the same perception or views as people who are willing received the Covid-19 vaccine.

show abstract

Section: Proceeding the First Muhammadiyahmentioning

confidence: 99%

Willingness of Indonesian Public on The Vaccination Programme as an Effort to Prevent Covid-19

Olivina

2021

MIPHMP

View full text Add to dashboard Cite

show abstract

The Effect of Atorvastatin on Lipid Profile and Inflammatory Marker in patient with Diabetes Dyslipidemia

Bellatasie

Suharjono

Samsulhadi³

et al. 2022

RJPT

View full text Add to dashboard Cite

Inflammation is the underlying cause of several comorbid diseases, including macrovascular complications that cause the highest mortality in diabetes patients. One of the pro-inflammatory cytokines used to assess inflammatory conditions in diabetes and its complications is IL-6. This study intends to analyze the effect of atorvastatin administration on lipid profile and inflammatory markers after 30 days and the correlation between lipid profile and IL-6. An observational prospective cohort study was conducted from November 2017 to January 2018 and approved by the ethical committee of General Hajj Hospital, Surabaya. Nineteen patients who met the inclusion criteria and signed the informed consent enrolled in this study. The measurement of lipid profile and IL-6 level were done twice, before and after 30 days of atorvastatin therapy. After atorvastatin administration, there was a 40.55% decrease in LDL level, a 15.34% decrease in TG level, a 30.70% decrease in total cholesterol level, which was statistically significant (p<0.05), and a 6.06% increase in HDL level. There was a 5.76% decrease in the IL-6 level (p>0.05). In conclusion, atorvastatin administration can improve lipid profile in diabetes patients with dyslipidemia. There was a decrease in IL-6 but not statistically different. From statistical analysis, there is no correlation found between lipid profile and IL-6

show abstract

Effect of Atorvastatin Treatment on Vascular Aterogenic Factors (Lipid Profiles and VCAM-1) in Patient Diabetes with Dyslipidemia

Cited by 2 publications

References 5 publications

Willingness of Indonesian Public on The Vaccination Programme as an Effort to Prevent Covid-19

Willingness of Indonesian Public on The Vaccination Programme as an Effort to Prevent Covid-19

The Effect of Atorvastatin on Lipid Profile and Inflammatory Marker in patient with Diabetes Dyslipidemia

Contact Info

Product

Resources

About